Volitionrx (VNRX) Net Equity Issued and Repurchased (2011 - 2025)

Volitionrx's Net Equity Issued and Repurchased history runs 15 years deep, the most recent figure standing at $6.7 million for Q4 2025.

• Quarterly Net Equity Issued and Repurchased rose 231.36% year-over-year to $6.7 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $11.2 million (up 30.01% YoY) and the FY2025 annual result came in at $11.2 million, up 30.01% from the prior year.
• Net Equity Issued and Repurchased was $6.7 million for Q4 2025 at Volitionrx, up from $2.0 million in the prior quarter.
• Across five years, Net Equity Issued and Repurchased topped out at $20.3 million in Q1 2021 and bottomed at -$85567.0 in Q3 2023.
• A 5-year average of $4.8 million and a median of $2.0 million in 2024 frame the typical range for Net Equity Issued and Repurchased.
• Peak annual rise in Net Equity Issued and Repurchased reached 581785633.33% in 2023, while the deepest fall reached 101.44% in 2023.
• Volitionrx's Net Equity Issued and Repurchased stood at $1.8 million in 2021, then slumped by 56.15% to $781794.0 in 2022, then jumped by 231.59% to $2.6 million in 2023, then dropped by 21.82% to $2.0 million in 2024, then jumped by 231.36% to $6.7 million in 2025.
• Business Quant data shows VNRX's Net Equity Issued and Repurchased at $6.7 million in Q4 2025, $2.0 million in Q3 2025, and $62560.0 in Q2 2025.